Global Pandemic Preparedness Summit 2024
July 29–30, Rio de Janeiro, Brazil
Provisional agenda
On July 29-30, 2024, The Ministry of Health, Brazil, Fundação Oswaldo Cruz (Fiocruz), and the Coalition for Epidemic Preparedness Innovations (CEPI) will host The Global Pandemic Preparedness Summit 2024.
The Summit aims to reinvigorate momentum for pandemic preparedness and response—helping to ensure that we can end future infectious disease outbreaks faster and more equitably.
The Global Pandemic Preparedness Summit 2024
This two-day in-person Summit will be hosted in Rio de Janeiro, Brazil, between July 29 and 30. It will bring together R&D and manufacturing experts, government officials, civil society representatives and leaders from industry and the global health community.
The Summit will focus on three central themes of the global pandemic preparedness agenda that, if aligned, could transform the world’s ability to respond quickly and equitably to the next Disease X threat. The Summit will also be live-streamed and a recording will be made available online after the event.
Summit Focus Areas
Equitable access to vaccines, medicines and other health technologies through geographical diversification and strengthening of R&D and local and regional production
By bolstering local and regional capacity and capability to produce health technologies in underserved regions, the world can respond to epidemic and pandemic threats more equitably
Delivering the 100 Days Mission for vaccines, diagnostics and therapeutics
To prevent future outbreaks from spiralling into pandemic threats, the world needs the ability to develop pandemic-busting vaccines, tests and treatments within 100 days of pathogen identification and for these innovations to be accessed equitably. This goal—known as the 100 Days Mission—has been embraced by leaders of the G7 and G20.
Enhancing global disease surveillance
Disease surveillance is crucial for identifying and responding to emerging pandemic threats. Effective surveillance systems are essential to detecting disease outbreaks quickly before they spread, cost lives and become difficult to control.
Summit partners
The Global Pandemic Preparedness Summit 2024 programme is co-designed with partners including FIND, the International Pandemic Preparedness Secretariat, the Pan American Health Organization (PAHO), Unitaid, WHO Hub for Pandemic and Epidemic Intelligence, and WHO.
List of organisations confirmed to attend
To see a list of organisations confirmed to attend the Global Pandemic Preparedness Summit 2024, please view this document.
Summit speakers
The Global Pandemic Preparedness Summit 2024 will bring together an exciting line-up of expert speakers and thought leaders to discuss challenges and progress needed to build a world that is better prepared to equitably meet the challenges of viral threats. New confirmed speakers will be regularly updated on this page.
Dr Emmanuel Agogo
Director of Pandemic Threats, FIND
Dr Simon Agwale
CEO, Innovative Biotech
Dr Ayoade Alakija
Chair, FIND Board
Mr Aggrey Aluso
Aggrey Aluso, Director, Africa Region for the Pandemic Action Network (PAN)
Dr Jarbas Barbosa
Director, Pan American Health Organization (PAHO)
Ms Paula Barbosa
Associate Director, Vaccines Policy
Dr Nahid Bhadelia
Founding director, BU Center on Emerging Infectious Diseases
Prof John Brownstein
Professor of Pediatrics at Harvard Medical School
Emer Cooke
Executive Director of the European Medicines Agency
Dr Jakob Cramer
Director, Clinical Development, CEPI
Prof. Tulio De Olivera
Director, Centre for Epidemic Response and Innovation (CERI)
Dr Ruxandra Draghia-Akli
Chair, INTREPID Alliance Scientific Advisory Board
Dr Philippe Duneton
Executive Director, Unitaid
Prof Victor J. Dzau
President, United States National Academy of Medicine
Dame Prof Sarah Gilbert
Said Professor of Vaccinology, University of Oxford
Mr Adam Hacker
Director and Head of Global Regulatory Affairs and Quality, CEPI
Prof. Jane Halton
Chair of CEPI Board
Dr Richard Hatchett
Chief Executive Officer, CEPI
Dr Chikwe Ihekweazu
Assistant Director-General, WHO
Ms Nafisa Jiwani
Head of Global Health Initiatives, U.S. International Development Finance Corporation
Dr Rogério Gaspar
Director, Regulation and Prequalification World Health Organization
Ms Amanda Glassman
Executive Advisor to the President, Inter-American Development Bank
Mr Charles Gore
Executive Director, Medicines Patent Pool
H.E Dr. Jean Kaseya
Director General, Africa CDC
Dr David Kaslow
Director, Office of Vaccines Research and Review (OVRR), Center for Biologics Evaluation and Research (CBER), U.S. FDA
Ms Kate Kelland
Author of DISEASE X—The 100 Days Mission to End Pandemics and Chief Scientific Writer at CEPI
Dr Evelyn Gitau
Chief Scientific Officer, Science for Africa Foundation
Professor Ilona Kickbusch
Founder and Chair, Global Health Centre
Dr Marco Krieger
Vice-President of Production and Innovation in Health, Fiocruz
Dr Frederik Kristensen
Managing Director, Regionalized Vaccine Manufacturing Collaborative (RVMC)
Dr Virgil Kuassi Lokossou
Acting Executive Director/Regional Center for Surveillance and Disease Control (RCSDC), West African Health Organisation (WAHO)
Ms Shingai Machingaidze
Co-Chair of the Science & Technology Expert Group, IPPS
Dr Morena Makhoana
CEO, BIOVAC
Dr Jairo Méndez-Rico
Advisor, Viral Diseases, PAHO
Dr Delese Mimi Darko
CEO, FDA Ghana
Prof Mario Moreira
President, A Fundação Oswaldo Cruz (Fiocruz)
Dr Oliver Morgan
Director, Pandemic and Epidemic Intelligence Systems, WHO Hub for Pandemic and Epidemic Intelligence
Mr Laurent Muschel
Acting Director General, European Commission, Health Emergency Preparedness and Response Authority (HERA)
Dr Mona Nemer
Chief Science Advisor, Government of Canada
Ms Carmen Pérez Casas
Strategy lead & PPPR Head, Unitaid
Ms Heulwen Philpot
Head of the International Pandemic Preparedness Secretariat
Dr Luis Pizarro
Executive Director, DNDi
Ms Joy Phumaphi
Co-Chair, Global Preparedness Monitoring Board
Dr David Reddy
Director General, IFPMA and Secretary of the Biopharmaceutical CEO Roundtable
Mr Tiago Rocca
Strategic Partnerships and Business Development Director, Instituto Butantan
Dr Amadou Alpha Sall
CEO, Institut Pasteur de Dakar in Senegal
Ambassador Tovar da Silva Nunes
Ambassador and Permanent Representative, Permanent Mission of Brazil to the United Nations
Dr Mariângela Simão
Director-President of the Instituto Todos pela Saúde
Mr Rajinder Suri
CEO, Developing Countries Vaccine Manufacturers Network (DCVMN)
Professor Petro Terblanche
CEO, Afrigen Biologics & Vaccines
Dr Marcela Uhart
Director, Latin America Program at the University of California Davis, School of Veterinary Medicine
Mr Andrea Zambon
Senior Director, Corporate Business Development, Stevanato Group
Dr Mauricio Zuma Medeiros
CEO, Bio-Manguinhos
Global Summit to bolster pandemic preparedness
The Global Pandemic Preparedness Summit 2024 in Rio de Janeiro, Brazil, will help to build a world that is better prepared for pandemic threats.
The Global Pandemic Preparedness Summit 2022: On the road to 100-Day vaccines
Catch-up on the key highlights from the The Global Pandemic Preparedness Summit 2022.
